chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to an unspecified amount of patients of unknown demographics. No patients' concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with improperly stored doses of GARDASIL injection (strength, dose, route of administration, lot# and expiry date unspecified). No concomitant medications were reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
On Saturday, January 23, I discovered a red, itchy hot spot approximately 3? by 3 ? located approximately 1 inch below injection site.  It ?grew? to approximately 5 by 5 inches within 48 hours.  Took Benedryl and seems to be improving.
Urine flow is depleted, started 24 hours after receiving the vaccine, About 2 weeks and nothing has changed; Feels like a little kid; Very low pressure; Like some sort of prostate issue; This spontaneous case was reported by a consumer and describes the occurrence of URINE FLOW DECREASED (Urine flow is depleted, started 24 hours after receiving the vaccine, About 2 weeks and nothing has changed), FEELING ABNORMAL (Feels like a little kid), HYPOTENSION (Very low pressure) and PROSTATITIS (Like some sort of prostate issue) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Accident (Car accident) in 2012, Broken nose in 2012, Broken jaw in 2012, Rib fracture in 2012, Anterior cruciate ligament tear in 2012 and Facial operation in 2012. Concurrent medical conditions included Traumatic brain injury (Cleft skull) since 2012. Concomitant products included PROPRANOLOL, PHENYTOIN and RISPERIDONE for Brain injury.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced URINE FLOW DECREASED (Urine flow is depleted, started 24 hours after receiving the vaccine, About 2 weeks and nothing has changed), FEELING ABNORMAL (Feels like a little kid), HYPOTENSION (Very low pressure) and PROSTATITIS (Like some sort of prostate issue). At the time of the report, URINE FLOW DECREASED (Urine flow is depleted, started 24 hours after receiving the vaccine, About 2 weeks and nothing has changed) had not resolved and FEELING ABNORMAL (Feels like a little kid), HYPOTENSION (Very low pressure) and PROSTATITIS (Like some sort of prostate issue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient was scheduled for his second dose on 20-Jul-2021. No treatment medication was reported. patient states does not want to have to start using a catheter
9 DAYS POST INJECTION, RASH AT THE INJECTION SITE.  NOTICED 1/13/21 AM WHEN i WENT TO SHOWER.  AREA IS WARM TO TOUCH.
This spontaneous report was received from the patient's mother refers to her daughter a 17 month old female patient. Concurrent conditions, medical history and allergies were not reported. On an unknown date, the patient was vaccinated with a first dose of VARIVAX (Merck), (strength, dose, route, anatomical location, lot number and expiration date were not reported). It was reported that the patient received a second dose of VARIVAX (Merck) on an unknown date with 5 weeks between vaccinations. The reporter query if they should had another vaccination to maximize immunity. Additional information has been requested.
Patient called the pharmacy to inform us of her side effects. She stated that after the vaccine she had the regular sore arm, muscle aches and pain, swelling and redness at injection site, diarrhea and headache (72 hours). The swelling at injection site didn't go down until day 6.  On day 7 it came back worse than it started and the patient went into her doctor and they decided it may be a delayed reaction response. At last time of contact patient was going into doctor office again thinking she may need to start antibiotics as it may be cellulitis. The injection site was very far back on the deltoid and MD thinks it may have gone into the soft tissue instead of the muscle.
Increase temperature; Dizziness; severe headache; felt sicker from the vaccine than when she had the virus; Sore throat; Body ache; very intense reaction; This spontaneous case was reported by a consumer and describes the occurrence of   in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for an unknown indication.     The patient's past medical history included No adverse event (No relevant medical history).    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age who had numerous allergies and received numerous allergy shot. On an unknown date the patient was vaccinated with PNEUMOVAX 23. The pharmacist reported that "getting the pneumonia vaccine almost killed her". The outcome of event was unknown. The relationship between event and therapy was unknown. Additional information has been requested.
Swelling and pain of the parotid gland in the neck starting the day after getting the vaccine
6pm: Screaming for over an hour, not feeding, swollen thigh, odd behavior, and red rash. 7:30pm- 1am: Went to ER given Tylenol & ibuprofen. Still crying and whining. Keep in touch with pediatrician through night. Finally feel asleep at 9 pm then ate. Kept crying.  1am- home. 1am-9am:  slept without waking to feed and had to be woken up. 4/8/14: Feed well, took 1 ml of Tylenol. sleepy throughout day, half-dollar size red rash. No swelling, still irritable, 4pm: rectal temp. 100.4, given 2.5 ml of Tylenol.
Patient was sleeping around 4:25 pm woke up looks like in so much pain she tried to cry but she had trouble to breath then the who body turns blue. I picked her up she still trying to cry but with shortness of breath still blue. I called her doctor's clinic they suggest to call 911, which I did and when the came she already cry out loud but still in so much pain and she looks so weak till they bring her to the hospital for further check.
After these 2 shots, my menstrual cycle was 3 weeks late and much heavier than usual (it came 3 weeks after the 2nd dose, for a total of 7 weeks between cycles).
Fever at 99 F. Runny nose, bad cough, headache, tired for 2-3 days.
3 days after the 1st vaccine- inflammation in joints, pain in old injury locations, muscle, tendon pain. Muscle spasms.  Extreme for 2 weeks.  Barely being able to walk in the mornings, Unable to do my normal daily runs.   The  following  6-7 weeks the pain continued ( not as extreme but not good)  Endurance, strength, remained low.  Fatigue  I'm over 3 months since the vaccine(s)- Injection spot still feels like a torn muscle, endurance and strength still not back to normal, heaviness in breathing, fatigue. pain in chest during intense training days, achy tingling arms.
Moderna/Dose number: 2; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 60-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), as dose 2, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Some kidney issues" (unspecified if ongoing), notes: Some kidney issues. Took renal dose of Paxlovid. Concomitant medication(s) included: LEXAPRO. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Moderna/Dose number: 2"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Other medication in 2 weeks was Statin. No known allergies. Took renal dose of Paxlovid. The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recvd vax 18AUG95 & in AUG95 pt exp a generalized outbreak of varicella w/approx 500 lesions;No further details were provided;
Pemphigus Vulgaris/blisters show up all over her body; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Aug2022 as dose 3 (booster), single (Lot number: FP4554) at the age of 35 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (lot number=EW0161, dose number=2, vaccine location=Left arm), administration date: 15Apr2021, when the patient was 34-year-old, for COVID-19 immunization; BNT162b2 (lot number=EN6207, dose number=1, vaccine location=Left arm), administration date: 19Mar2021, when the patient was 34-year-old, for COVID-19 immunization. The following information was reported: PEMPHIGUS (hospitalization, disability, life threatening) with onset 07Aug2022, outcome "not recovered", described as "Pemphigus Vulgaris/blisters show up all over her body". The patient was hospitalized for pemphigus (hospitalization duration: 3 day(s)). The event "pemphigus vulgaris/blisters show up all over her body" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of pemphigus. Clinical course: Patient started to have blisters show up all over her body just a couple of days after her 3rd shot. She ended up hospitalized and then was diagnosed with Pemphigus Vulgaris. Adverse event treatment: Steroids, Rituximab. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. Hospitalization 3 days.
dizzy. light headed, weak, headache, shortness of breath, low 02, heart rate high.
A non-serious spontaneous report of nurse went to school to administer FLUMIST and developed rash on index finger has been received from a health professional concerning herself, an adult female, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient did not receive FLUMIST. The patient was a public health nurse who went into a school to administer FLUMIST. She administered FLUMIST throughout the months of November and December 2010 and developed a rash on her index finger in November. The patient stated that the rash recently returned and she had not dispensed FLUMIST. The outcome of the nurse went to school to administer FLUMIST and developed rash on index finger was resolved. The reported assessed the event of rash as probably not related to FLUMIST. Additional information was received on 23-Mar-2011 and incorporated into the narrative: reporter information, outcome of the event rash and reporter causality.
Pt recvd vax 31JUL92 1130AM & became listless, pale c/o n/v 1134 placed in trendelenburg postion BP 50/30 cont pale, disoriented c/o n/v 1136AM, pale diaphoretic, cyanotic; pt taken to ER seen by MD dx somelence, cyanpiol episode, vaso-vaga
Erythema, induration and swelling of L deltoid  with few weeping vesicles
at 1500 BP 154/107, Pulse 128 O2 sat 98%.   Reports Rt side of face feels hot.  Appears nervous, tearful at times.  upper cheeks blotchy red bilaterally.  At 1508 BP 159/105, Pulse is at 130,  at 1513 BP 137/98 Pulse 104, O2 sat 98% Respirations 16.  Reports hx of racing heart whenever she gets certain IV drugs such as pain meds, Benadryl, etc.  Reports also feeling tired.  at 1608 reports feeling tired and that her face and ears still hot.  Face and ears are blotchy red.  had not mentioned that her ears felt hot earlier in the event.  BP is 126/93, Pulse 85, Respirations 16, Patient states that her husband will be coming to pick her up.  Instructed patient that when she has her 2nd dose she should probably bring someone with her and that if symptoms worsen she should call her PCP or go to emergency room depending on severity.
Patient had a seizure lasted for about 30 seconds in the waiting room about 3-5 minutes after getting Fluvirin flu shot. No Epipen was required. Was lucid (was able to tell location and time) about 1 minutes afterwards, was tired. Paramedics came about 6:05 PM. Paramedics, pt, and family left about 6:20 PM for hospital observations. Per mom, patient was discharged that same Saturday night.
No adverse effect; multiple patients were vaccinated with improperly stored VARIVAX; This spontaneous report was received from a medical assistant referred to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-FEB-2019, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX)(dose and strength were not reported, lot # R019235 and expiry date 04-JUL-2020) via unknown route for prophylaxis and no adverse effects were reported (product storage error and no adverse event). Other suspect therapies included sterile diluent (dose, strength, route, lot # and expiration date were not reported). There was a previous temperature excursion and the time frame and temperature was unknown. Digital data logger was involved. There was no involvement of Product quality complaint (PQC). This is one of the several reports received from the same reporter.
Delayed Menstrual cycle. Menstrual cycle began in between doses of the COVID19 vaccine (1st dose: 12/07/2021). Cycle start date was 12/21/2021 and lasted 47 days, 19 days longer than typical. The second menstrual cycle post vaccination has also been irregular, with cycle start date 02/06/2022 and is currently delayed longer than typical, by two days and counting.  Other non-menstrual adverse effects: headache, fever, body ache, lethargy.
24hr after vaccination - red circular spots on muscle where shot given. Hot to touch and spots became hard. fingers were numb few hours after flu shot, but this went away. Still appears pink, but MD says he believes it is going away.
Much energy on first day. Then severe spasms in legs and hands, unable to flex. Breathing labored. I believe it was injected into my left arm muscle.
Pt reports received 1st dose of moderna vaccine on 3/5 to R arm. On Saturday 3/6 he noted red rash to R side of his neck and black/blue dot rash on L side of neck. Also had mild fever, pain and injection site, chills. Denies any issues with breathing or swallowing. Reports today 3/8 that rash is about 90% resolved. He will continue to monitor.
Patient experiences swelling of throat and eyes 4 hours after the vaccination. Although there were no complaints of injection site. Patient was not experiencing difficulty breathing at this time. Directed to take Benadryl and to seek medical attention.
administered only the liquid conjugate portion; administered only the liquid conjugate portion; This case was reported by a physician via call center representative and described the occurrence of inappropriate preparation of medication in a adolescent male patient who received Men ACWY-CRM NVS (batch number AMVA659A, expiry date 31st January 2023) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The age at vaccination was not reported. Physician reported that a patient was administered only the liquid conjugate portion of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Only month and year for expiration date so last day of the month was chosen for this form . The reporter consented to follow up.
extreme tiredness starting a day after the shot continuing thru today.  Also, on 4/6, my left ear started making a crackling noise.  visited doc, but just said to take flonase and tylenol and start my allergy meds.
MIGRAINE; DIARRHEA; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-MAR-2021, the subject experienced migraine. On 05-MAR-2021, the subject experienced diarrhea. On 05-MAR-2021, the subject experienced chills. On an unspecified date, the subject experienced bad shortness of breath, and couldn't climb a flight of stairs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bad shortness of breath, migraine, and chills, and diarrhea on 05-MAR-2021, and was recovering from couldn't climb a flight of stairs. This report was non-serious.
After first vaccine administration pt developed slurred speech that has not improved. After second vaccine administration patient developed difficulty with balance.
This spontaneous report as received from an office manager refers to an unknown number of patients of unknown age and gender. On an unknown dates in 2016, reported as since August 2016, the patients were inadvertently vaccinated with GARDASIL 9 lot # M017983, expiration date 30-MAY-2018 that had been improperly stored. No adverse event was reported. Administered doses of vaccines experienced the temperature of 32 degrees Fahrenheit for 30 minutes. This is one of several reports received from the same reporter. Additional information is not expected as there is no consent to contact a healthcare professional.
5/07 general ill feeling; runny nose, watery eyes. continued until 5/10. Wife denied fever or cough.  continued until 5/10. 5/11 at work, patient collapsed. Was awake but non-responsive, breathing on his own, vomited shortly before EMS arrived. EMS arrived, patient stopped breathing, was bagged until arrival at hospital where he was intubated.   5/12 Patient was extubated and died in early AM 5/13.  Medical records state cerebral brain hemorrhage.
This spontaneous report was received from a nurse, concerning a child patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions, drug reactions/allergies or concomitant medications. On an unknown date, the nurse attempted to administer a dose of VAQTA 25U/0.5ml PED (pediatric) lot # R010368 with expiration date of 25-MAR-2019, for prophylaxis, but the plunger fell out of the syringe barrel (product quality issue) after touching the patient but before administering the dose. A second syringe was obtained and a dose of VAQTA was administered intramuscularly, during the same office visit for prophylaxis (dose, anatomical location, lot number and expiration date were not reported). The outcome of product quality issue and the causal relationship between product quality issue and therapy with VAQTA was not provided.
14 year old patient inadvertently administered Moderna vaccine.  Monitored patient for 30 minutes without any adverse events
L arm 3x4cm induration, redness, itchiness at site of injection.  Rx for Benadryl and hydrocortisone 1%
Patient was waiting in our observation area when he began to experience dizziness, cold sweats and tunnel vision.  He lay down on the floor, and our technician asked him if he was OK.  I immediately went out to him, and he told me he was already feeling better.  I had him put his feet up on the chair, and he told me that he thought this reaction was due to anxiety.  He was talking and breathing  normally.  I offered to check his blood pressure and get him some water, but he declined.  He rested on the floor for approximately 5 minutes and then said he was feeling well enough to go.
Pt received immunization on 11/26/07 approx. 6PM at time of admin. Parent report period of decreased responsiveness starting approx 0300 11/27/07, lasted about 3 hrs. No seizure activity. Started with fever, T101 late on 11/27/07. Brought to hospital where was hospitalised 11/28 - 11/30/07.  2/1/2008 MR received for DOS 11/28-30/2008 with D/C Dx Viral Gastroenteritis. Infant presented to ER with 3 day hx of fevers and vomiting which began day of admission.  Parent also reported episode of chest convulsions/dry heaves followed by lethargy.
Client received her 2nd Moderna shot (Lot# 024C21A) at 15:40 and client's mother was accompanying her.  After receiving the shot, client went to observation room to sit in a chair.  At 15:45 EMT noticed client feeling drowsy.  EMT approached client and her mother.  Client stated she felt like she was going to pass out.  Mother helped client stay upright in chair while EMT grabbed recliner chair.  EMT transferred client to recliner chair and notified Lead RNs over waki taki.  EMT took client's vitals at 15:50 (BP:  122/82, HR:  78) and gave client a bottle of water.  Lead RN arrived in observation room at 15:52. EMT communicated that client was clammy, diaphoretic and nauseous.  Client stated she was already feeling better and that the symptoms only lasted 2 minutes.  Client stated she was not experiencing SOB or difficulty breathing.  Client was alert and oriented times 4.  Client also stated she experienced the same exact symptoms after her 1st dose of Moderna.  Client stated she feels like she is going to pass out when she gets shots, but that it passes quickly.  Client stated she has no underlying conditions, takes no medications, and has no known allergies.  Client also stated she did not take any medication or receive treatment for these symptoms after receiving her 1st Moderna dose.  Client stated she ate and drank plenty prior to getting her 1st and 2nd shot and was feeling completely fine.  Client sat up in the recliner chair and sat for a bit longer.  EMT took vitals again at 16:14 (BP:  132/96 HR:  82, RR:  16).  Client stood up from chair and felt fine.  Client left with mother at 16:18. Client walked upright with a steady gait when leaving.